Literature DB >> 17463227

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

Pontus Lundberg1, S El-Andaloussi, T Sütlü, H Johansson, U Langel.   

Abstract

Cell-penetrating peptides (CPPs) are peptides able to promote uptake of various cargos, including proteins and plasmids. Advances in recent years imply the uptake to be endocytic, where the current hurdle for efficient intracellular delivery is material being retained in the endosomes. In this study we wanted to compare the ability of various established CPPs to deliver siRNA and induce gene silencing of luciferase, with a novel designed penetratin analog having endosomolytic properties, using a noncovalent strategy. In principal, the penetratin analog EB1 will, upon protonation in the early-late endosomes, be able to form an amphipathic alpha helix resulting in permeabilization of the endosomal membrane. We demonstrate that even though all CPPs evaluated in this study can form complexes with siRNA, there is not a direct relationship between the complex formation ability and delivery efficacy. More important, although all CPPs significantly promote siRNA uptake, in some cases no gene silencing effect can be observed unless endosomal escape is induced. We find the designed endosomolytic peptide EB1 to be far more effective both in forming complexes and transporting biologically active siRNA than its parent peptide penetratin. We believe that developing CPPs with increased endosomolytical properties is a necessary step toward achieving biological effects at low concentrations for future in vivo applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17463227     DOI: 10.1096/fj.06-6502com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  78 in total

1.  Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting.

Authors:  Vijaya Gopal; Kunchur Guruprasad
Journal:  Syst Synth Biol       Date:  2011-02-17

2.  A cell-penetrating helical polymer for siRNA delivery to mammalian cells.

Authors:  Nathan P Gabrielson; Hua Lu; Lichen Yin; Kyung Hoon Kim; Jianjun Cheng
Journal:  Mol Ther       Date:  2012-05-29       Impact factor: 11.454

Review 3.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

Review 4.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

5.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

Authors:  Laurence Crombez; Gudrun Aldrian-Herrada; Karidia Konate; Quan N Nguyen; Gary K McMaster; Robert Brasseur; Frederic Heitz; Gilles Divita
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

6.  Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies.

Authors:  Laurence Dutot; Pascaline Lécorché; Fabienne Burlina; Rodrigue Marquant; Vanessa Point; Sandrine Sagan; Gérard Chassaing; Jean-Maurice Mallet; Solange Lavielle
Journal:  J Chem Biol       Date:  2009-11-10

7.  Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing.

Authors:  Pim-on Rujitanaroj; Brian Jao; Junghoon Yang; Feng Wang; James M Anderson; Jun Wang; Sing Yian Chew
Journal:  Acta Biomater       Date:  2012-10-02       Impact factor: 8.947

8.  Melittin derived peptides for nanoparticle based siRNA transfection.

Authors:  Kirk K Hou; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

9.  Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.

Authors:  Angela A Alexander-Bryant; Anca Dumitriu; Christopher C Attaway; Hong Yu; Andrew Jakymiw
Journal:  J Control Release       Date:  2015-09-18       Impact factor: 9.776

10.  Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters.

Authors:  Amir Nasrolahi Shirazi; Donghoon Oh; Rakesh Kumar Tiwari; Brian Sullivan; Anju Gupta; Geoffrey D Bothun; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-11-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.